Music |
Video |
Movies |
Chart |
Show |
Combined Targeting Against VEGF and PD-1 in Bladder Cancer (OncLive) View | |
Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1 antibody (ecancer) View | |
Beyond Checkpoint Inhibition: New Therapeutic Approaches to Bladder Cancer (Grand Rounds in Urology) View | |
New Targets for Advanced Bladder Cancer (Grand Rounds in Urology) View | |
Targeting VEGF in Gastric/GEJ Cancer Treatment (OncLive) View | |
Potential Targets in Muscle-Invasive Bladder Cancer (OncLive) View | |
Atezolizumab Unveiling the Role of Anti-PD-L1 in Cancer Research (Assay Genie) View | |
Checkpoint Inhibitors (Grand Rounds in Urology) View | |
Oncolytic Viruses: Melanoma and Bladder Cancer (OncLive) View | |
Highlighting Clinical Trials: Advanced/Metastatic Bladder Cancer | Part I (Bladder Cancer Advocacy Network) View |